| Certification: | BRC, ISO, HACCP, in-House Standard |
|---|---|
| Assay Method: | HPLC |
| Application Form: | Injection, Lotion, Paste, Tablet, Capsule |
| Application: | Food, Health Care Products, Medicine |
| State: | Powder |
| Extract Source: | Herb |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier | Product Name: | Kobophenol A |
| Description: | Kobophenol A has antimicrobial, and anti-inflammatory activities, it might be a candidate for treatment of inflammatory bone diseases relevant to osteoblast cell death. Kobophenol A inhibits AChE activity in a dose-dependent manner, and the IC50 value is 115.8mM. Kobophenol A has protective effect against nitrosative/oxidative or mitochondrial damages resulted in the inhibition of the ROS, intracellular calcium ion level, and mitochondrial transmembrane potential changes on SH-SY5Y cells. Kobophenol A, identified through docking studies, is the first compound that inhibits CoV-2 binding to cells through blocking S1-RBD to the host A receptor and thus may serve as a good lead compound against. |
| CAS: | 124027-58-3 |
| MF: | C56H44O13 |
| Source: | The herbs of Carex humilis Leyss. |
| Solvent: | DMSO, Pyridine, Methanol, Ethanol, etc. |
| Size /Price /Stock | 10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.5179 mL | 17.5895 mL | 35.1791 mL | 70.3581 mL | 87.9477 mL |
| 5 mM | 0.7036 mL | 3.5179 mL | 7.0358 mL | 14.0716 mL | 17.5895 mL |
| 10 mM | 0.3518 mL | 1.759 mL | 3.5179 mL | 7.0358 mL | 8.7948 mL |
| 50 mM | 0.0704 mL | 0.3518 mL | 0.7036 mL | 1.4072 mL | 1.759 mL |
| 100 mM | 0.0352 mL | 0.1759 mL | 0.3518 mL | 0.7036 mL | 0.8795 mL |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}